FDA Cracks Down on Telehealth Firms for 'Misleading' Weight‑Loss Drug Claims

Cheddar News 2025-09-17

Views 30

The FDA has issued over 100 warning letters to drug makers and online health firms, including Hims & Hers, for promoting compounded versions of popular GLP‑1's.
Show more

Share This Video


Download

  
Report form
RELATED VIDEOS
U.S. Hits Russia’s Top Oil Firms with Sanctions as Trump Cancels Meeting with Putin
play
00:31

U.S. Hits Russia’s Top Oil Firms with Sanctions as Trump Cancels Meeting with Putin
U.S. Firms Project 3.9% Pay Raise For 2025
play
00:26

U.S. Firms Project 3.9% Pay Raise For 2025
U.S. Firms Project 3.9% Pay Raise For 2025
play
00:34

U.S. Firms Project 3.9% Pay Raise For 2025